Our Experience and Literature Update Regarding Concomitant Radiotherapy with CDK4/6 Inhibitors and Hormonal Therapy in Metastatic Breast Cancer

Our Experience and Literature Update Regarding Concomitant Radiotherapy with CDK4/6 Inhibitors and Hormonal Therapy in Metastatic Breast Cancer

Background and Objectives: Standard treatment in metastatic breast cancer with positive estrogen receptors and negative HER2neu is represented by CDK4 inhibitors combined with aromatase inhibitors or fulvestrant. Palliative radiotherapy is indicated for symptoms or local–regional control. Multiple p...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura-Florentina Rebegea, Dorel Firescu, Oana-Gabriela Trifanescu, Roxana-Andreea Rahnea-Nita, Liviu Bilteanu, Mihaela Dumitru, Florentina Lacatus, Gabriela Rahnea-Nita
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Journal of Mind and Medical Sciences
Subjects:
CDK4/6 inhibitors
toxicity
metastatic breast cancer
Online Access:https://www.mdpi.com/2392-7674/12/1/33
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2392-7674/12/1/33

Similar Items